Want to join the conversation?
$RCL's net cash used in investing activities for 1Q16 decreased to $236.7MM from $399.6MM in 1Q15. The decrease was due to a decline in capital expenditures on lower cash deposited associated with its ships on order, cash received on settlements on foreign currency forward contracts, and no investments in loans to its unconsolidated affiliates.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.